Antibody-induced acetylcholine receptor clusters inhabit liquid-ordered and liquid-disordered domains by Kamerbeek, Constanza Belén et al.
Biophysical Journal Volume 105 October 2013 1601–1611 1601Antibody-Induced Acetylcholine Receptor Clusters Inhabit Liquid-Ordered
and Liquid-Disordered DomainsConstanza B. Kamerbeek,† Virginia Borroni,† Marı´a F. Pediconi,† Satoshi B. Sato,‡ Toshihide Kobayashi,‡
and Francisco J. Barrantes†§*
†Instituto de Investigaciones Bioquı´micas de Bahı´a Blanca, Bahı´a Blanca, Argentina; ‡Lipid Biology Laboratory, RIKEN, Saitama, Japan; and
§Laboratory of Molecular Neurobiology, Institute for Biomedical Research UCA-CONICET, Faculty of Medical Sciences, Catholic University of
Argentina, Buenos Aires, ArgentinaABSTRACT The distribution of nicotinic acetylcholine receptor (AChR) clusters at the cell membrane was studied in CHO-K1/
A5 cells using fluorescence microscopy. Di-4-ANEPPDHQ, a fluorescent probe that differentiates between liquid-ordered (Lo)
and liquid-disordered (Ld) phases in model membranes, was used in combination with monoclonal anti-AChR antibody labeling
of live cells, which induces AChR clustering. The so-called generalized polarization (GP) of di-4-ANEPPDHQ was measured in
regions of the cell-surface membrane associated with or devoid of antibody-induced AChR clusters, respectively. AChR clusters
were almost equally distributed between Lo and Ld domains, independently of receptor surface levels and agonist (carbamoyl-
choline and nicotine) or antagonist (a-bungarotoxin) binding. Cholesterol depletion diminished the cell membrane mean
di-4-ANEPPDHQ GP and the number of AChR clusters associated with Ld membrane domains increased concomitantly. Depo-
lymerization of the filamentous actin cytoskeleton by Latrunculin A had the opposite effect, with more AChR clusters associated
with Lo domains. AChR internalized via small vesicles having lower GP and lower cholesterol content than the surface mem-
brane. Upon cholesterol depletion, only 12% of the AChR-containing vesicles costained with the fluorescent cholesterol analog
fPEG-cholesterol, i.e., AChR endocytosis was essentially dissociated from that of cholesterol. In conclusion, the distribution of
AChR submicron-sized clusters at the cell membrane appears to be regulated by cholesterol content and cytoskeleton integrity.INTRODUCTIONNicotinic acetylcholine receptors (AChRs) are members of
the Cys-loop family of fast ligand (neurotransmitter)-gated
ion channels, all of which are pentameric transmembrane
receptor proteins. AChRs are expressed in central and peri-
pheral nervous systems, the neuromuscular junction and
the electromotor synapse of electric fish in the latter case.
AChR levels and surface organization are determinant for
the efficacy of cholinergic synaptic activity. This is evident
in the autoimmune disease myasthenia gravis, in which auto-
antibodies against AChR are present in ~85% of patients (1),
inducing the loss of surface AChRs from the neuromuscular
junction and resulting in serious impairment of synaptic
transmission (2,3). Loss of cell-surface receptors results
from an accelerated rate of AChR endocytosis, mimicked
in vitro in many cell systems including CHO K1/A5 cells,
a Chinese hamster ovary cell line generated in our laboratory
(4) that stably expresses adult muscle-type AChR (5–7).
When stained with fluorescent a-bungarotoxin (BTX)
and imaged with conventional widefield microscopy,
CHO-K1/A5 cells show a finely diffuse fluorescence stain-
ing at their surface (5,8). Plasma membrane sheets gener-
ated by cell unroofing enabled visualization of AChR
puncta as submicron-sized, diffraction-limited spots of
~200 nm (5). Using stimulated emission depletion superre-
solution microscopy (nanoscopy) and antibody labeling, theSubmitted May 29, 2013, and accepted for publication August 21, 2013.
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ters of ~55 nm (9). The organization and amount of these
antibody-induced AChR nanoclusters, as well as their
interrelationship, were found to be cholesterol (Chol)- and
cytoskeleton-dependent (5,9,10). This is remarkably similar
to the case of myotubes in culture (11–14), where associa-
tion of AChR with Chol-rich domains is required for the
formation and maintenance of AChR clusters. It was pro-
posed that Chol-rich membrane domains are involved in
AChR clustering by promoting local actin cytoskeleton
reorganization (15). Chol depletion induces the fragmenta-
tion of the relatively large, micron-sized AChR assemblies
found in muscle cells (11–14), thus suggesting the existence
of conserved mechanisms for maintaining ground levels of
surface AChRs (in the absence of nerve or muscle signaling)
and their proper supramolecular organization (16).
Segregation of proteins into membrane lipid domains of
different biophysical properties has been proposed as a
mechanism for the spatiotemporal regulation of signaling
and trafficking (17,18). In Torpedo electrical organ, AChR
arrays are embedded in a lipid microenvironment that dif-
fers in physical terms from the rest of the membrane bilayer
(19,20). This was also observed in C2C12 myotubes, in
which large micron-sized AChR clusters formed upon agrin
stimulation resided in more ordered membrane domains
(11). However, the effect of this association on AChR endo-
cytic trafficking has not as yet been explored in detail.
To date, Laurdan and di-4-ANEPPDHQ are two of the
most commonly used fluorescent probes for studyinghttp://dx.doi.org/10.1016/j.bpj.2013.08.039
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living cells. Both probes sense membrane polarity—i.e.,
the level of water penetration in the membrane—by display-
ing a blue-shift in their emission spectrum (21,22). The
so-called GP—used to calculate the degree of membrane
order—is obtained from the differences between the fluores-
cence emission properties of the dye in liquid-ordered (Lo)
and liquid-disordered (Ld) phases (23). It has been demon-
strated that the incorporation of proteins into liposomes does
not modify the emission spectra of Laurdan or di-4-
ANEPPDHQ (21), indicating the suitability of these probes
for studying membrane physical properties in living cells.
The main advantage of using di-4-ANEPPDHQ instead of
Laurdan is that the former is excited in the visible spectrum
(488 nm), whereas Laurdan requires excitation in the ultra-
violet range of the spectrum (24).
We have previously undertaken combined fluorescence
spectroscopy and patch-clamp studies of CHO-K1/A5 cells
and surface membranes prepared therefrom using the probe
Laurdan (25), enabling the correlation of the temperature-
dependent single-channel properties of the AChR with the
physical state of the host membrane derived from the
temperature-dependence of Laurdan GP. In this work we
attempted to obtain spatial information on the relationship
between AChR (nano)clusters and the physical state of the
host membrane lipid in which the receptors are embedded
using di-4-ANEPPDHQ GP. The results obtained highlight
the importance of membrane cholesterol and actin cytoskel-
eton integrity in the maintenance of small AChR nanoclus-
ters. We postulated that such aggregates resemble the
organization of supramolecular assemblies of receptors at
early embryonic developmental stages (16,26). Further-
more, these aggregates may also bear on the initial phase
of antibody-induced clustering in myasthenia.MATERIAL AND METHODS
Materials
Cholesterol, methyl-b-cyclodextrin (CDx), latrunculin A (Lat A), cytocha-
lasin D (Cyto D), nicotine (Nic), carbamoylcholine chloride (Carb), and
dimethyl sulfoxide (DMSO) were purchased from Sigma Chem. Co.
(St. Louis, MO). Jasplakinolide (Jaspl) was from Calbiochem (San Diego,
CA). BTX, Alexa Fluor647a-bungarotoxin (Alexa647BTX) and Alexa
Fluor647 antibodies were purchased from Molecular Probes (Eugene, OR)
or Invitrogen (Carlsbad, CA). The monoclonal antibody mAb 210 against
the main immunogenic region of the AChR a subunit was a gift from Dr.
Jon Lindstrom, Univ. of Pennsylvania Med. Center. The fluorescein ester
of polyethylene glycol-derivatized cholesterol (fPEG-Chol) was synthe-
sized in Prof. T. Kobayashi and Dr. Satoshi B. Sato’s laboratories. Di-4-
ANEPPDHQ was a gift from Prof. L. Loew, University of Connecticut
Health Center for Cell Analysis & Modeling, Farmington, CT.Cell culture
CHO-K1/A5 cells were grown in Ham’s F12 medium supplemented
with 12% fetal bovine serum at 37C for 2–3 days as previously
described (4).Biophysical Journal 105(7) 1601–1611Acute cholesterol depletion/enrichment of
cultured cells
CHO-K1/A5 cells were incubated at 37C for 30 min with different concen-
trations (5–15 mM) of CDx in medium 1 (M1:140 mM NaCl, 1 mM CaCl2,
1 mM MgCl2, and 5 mM KCl in 20 mM HEPES buffer, pH 7.4) to acutely
deplete their cholesterol content before fluorescent labeling as described
previously (5). The experiments in Fig. 3 were carried out using a final con-
centration of 15 mM CDx. For cholesterol enrichment experiments, CDx-
Chol complexes were prepared as in Christian et al. (27). Cells were
incubated with 15 mM Chol-CDx complexes (CDx/Chol 6:1) at 37C for
30 min.Disruption/stabilization of the actin meshwork
CHO-K1/A5 cells were incubated with 4 mM Lat A, 2.5 mM Cyto D, or 1
mM Jaspl at 37C for 2 h. Stock solutions of these drugs were made in
DMSO and working solutions were prepared by diluting the stock in M1.
As a control condition, cells were incubated with the maximum volume
of DMSO used, always below 0.5% DMSO in M1 (v/v).AChR internalization triggered by BTX ligation
As described previously by Kumari et al. (7), binding of antibody or BTX
triggers the internalization of the AChR. Here, cells were exposed to
500 nM BTX in M1 for 15 min at 4C. At the end of the incubation period
cells were washed thrice with cold M1 and shifted to 37C for 2 h. In the
experiments shown in Fig. 5 (only control BTX internalization) and
Fig. 6, Alexa647BTX was used instead of native BTX.AChR agonist treatment
Cells were incubated with 100 mMNic and 0.5 mM Carb at 37C for 30 and
50 min, respectively. Because agonist binding to the receptor is reversible,
cells were washed with cold M1 containing the same agonist concentration.Widefield fluorescence microscopy
CHO-K1/A5 cells were grown on 25mm diameter glass coverslips in Ham’s
F12 medium at 37C and then washed thrice with M1 medium. For surface
Chol staining, cells were incubated with 1 mM fPEG-Chol in M1 at 4C and
after washing with M1, observed under the microscope. Cell-surface AChR
labeling of CHO-K1/A5 cells was carried out by incubation of cells at 4C
for 1 h with mAb 210 and subsequently with Alexa647-labeled secondary
antibody (far red) at 4C for 1 h, before di-4-ANEPPDHQ treatment in
M1 at 4C for 15 min. Cells were subsequently rinsed thrice with 20 micro-
molar M1 and mounted for microscope examination. For all experiments a
100 (1.4 N.A.) oil-immersion objective was used for imaging in a Nikon
TE-300 inverted microscope. Appropriate dichroic and emission filters
were employed to avoid crossover of fluorescence emission. Sixteen bit im-
ages were exported for further offline analysis.Di-4-ANEPPDHQ imaging
After treatment, coverslips were mounted on a slide and immediately trans-
ferred to a Nikon TE-300 inverted microscope. Di-4-ANEPPDHQ was
excited by a mercury arc; 488 nm light was selected with a Z488/10
band-pass excitation filter (Chroma Technol., Rockingham, VT). Emitted
fluorescence was separated from excitation by a dichroic beam splitter
(Z488RDC, Chroma) and imaged via a dual-viewer instrument constructed
at the Department of NanoBiophotonics, Max Planck Institute for Bio-
physical Chemistry, Go¨ttingen, Germany. This multichannel imager split
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splitter (610 dplc, Chroma). Each beam was then spectrally isolated
with bandpass emission filters HQ575/50 and HQ680/50 (Chroma) and
imaged onto the two halves of a thermostatically cooled Hamamatsu
ORCA-ER C4742-95-12ERG (Hamamatsu Photonics, Hamamatsu City,
Japan) charge-coupled device (CCD) camera. To obtain the positionally
resolved GP values, fluorescence images were acquired with SlideBook
(Intelligent Imaging Innovations, Denver, CO). A quarter-wave plate
was placed before the dichroic mirror to reduce polarization-dependent
reflectance.GP of di-4-ANEPPDHQ
The images obtained with the dual-viewer setup required further fine offline
alignment. For this purpose, regions of interest (ROIs) of the two simulta-
neously recorded images were aligned using ad hoc routines in SlideBook
and tested for optimization of the two-dimensional alignment by applica-
tion of Pearson’s (28), Manders’ (29), and Costes et al. (30) algorithms
(see Fig. S1 in the Supporting Material). These algorithms quantify the
degree of colocalization of all pixels in the two 256  256 images split
into the two halves of the CCD camera.
Upon optimization of the colocalization images, the so-called GP of di-4-
ANEPPDHQ in the fluorescence images was calculated on a pixel basis
from the ratio of fluorescence intensities (I) of the blue-edge channel,
with recorded emission wavelengths between 550 and 600 nm (HQ575/
50m filter), and the red-edge channel (emission wavelength 655–705 nm,
HQ680/50m) based on the following equation:
GP ¼ I550600  I655705
I550600 þ I655705 (1)
GP distributions were obtained from the histograms of the GP images using
the software ImageJ (NIH, Bethesda, MD). Background values were set to
zero by converting the denominator of the GP function (Eq. 1 above) to a
binary image with background values set to zero, nonbackground values
set to one, and the binary image multiplied with the GP image as described
by Gauss et al. (31).
To validate the experimental system, we prepared giant unilamellar ves-
icles (GUVs) resembling ordered (DPPC/Chol, 7:3) and disordered
(DOPC) phases as in Jin et al. (2006) (Fig. S2). GUVs were imaged with
a TCS-SP2 confocal microscope (Leica Mikrosysteme Vertrieb GmbH,
Wetzlar, Germany) equipped with an acoustooptical beam splitter. Di-4-
ANEPPDHQ emission was collected in the blue-edge and red-edge
channels and GP images were generated. As shown in Fig. S2, di-4-
ANEPPDHQ successfully differentiates Lo and Ld phases.
When labeled at 4C with di-4-ANEPPDHQ, the fluorescence signal in
live CHO-K1/A5 cells is restricted almost exclusively to the plasma mem-
brane; essentially no internalization of the probe occurs in the time window
of 15 min at 4C (Fig. S3). The corresponding actual excitation and emis-
sion spectra of live CHO-K1/A5 cells in suspension as obtained in cuvette
experiments is shown in Fig. S4. As expected for a bulk measurement, a sin-
gle component for di-4-ANEPPDHQ fluorescence emission was observed.
The regions of the emitted fluorescence selected by the HQ575/50m (blue-
edge) and the HQ680/50m (red-edge) filters are superimposed onto the
emission spectrum.
As shown in Fig. S3, fluorescence images of di-4-ANEPPDHQ in a live
CHO-K1/A5 cell at the blue-edge (Fig. S3 A) and red-edge (Fig. S3 B) of
the spectrum exhibit different intensities but do not show heterogeneity,
even when the two images are superimposed and aligned (Fig. S3 C). How-
ever, when the spatially resolved GP images were generated, the uneven
distribution of the di-4-ANEPPDHQ GP values became apparent (Fig. S3
D). Regions of high GP (high order, pseudocolored in yellow/red) were
particularly noticeable in the thin filopodia and cell-surface protrusions
(arrows in Fig. S3 D). When the areas corresponding to the cell-surface
membrane were isolated by masking, mean GP values of control conditioncells ranged between 0.36 and 0.48. These figures depended on the
experimental conditions (incubation medium, temperature, etc.) before
di-4-ANEPPDHQ staining.Other quantitative image analyses
To measure the spatial relationship between AChR-positive areas with the
GP of di-4-ANEPPDHQ in those areas, 32-bit GP images were analyzed
with ImageJ after manually outlining ROIs in areas previously aligned
with SlideBook software. The average GP of several ROIs was measured
within the anti-AChR positive region and in regions of the plasma mem-
brane devoid of anti-AChR label. For illustration purposes, images were
processed using ImageJ, scaled with identical parameters, and pseudocol-
ored according to a custom-designed 16-color lookup table.
With the aim of evaluating AChR distribution in relation to membrane
mean GP, cells were incubated with the mAb 210 anti-AChR monoclonal
antibody followed by Alexa647-labeled secondary antibody. This labeling
procedure produces visible AChR clusters in the plasmalemma. After
di-4-ANEPPDHQ treatment and imaging, each AChR cluster was manu-
ally outlined, selected as a ROI, and analyzed for its GP value with Im-
ageJ. These GP values in AChR clusters were compared with the mean
membrane GP and classified into three groups: ROIs with GP values at
least 0.001 higher, lower, or equal to those of the mean membrane GP.
All experiments were repeated at least three times. In all experiments
the number of clusters in each group was normalized on the basis that
the total number of clusters in the experiment was equal to 100. Histo-
grams were made by averaging each group of clusters from different ex-
periments, thus reflecting the preference of AChR clusters for a given
range of GP values as compared with the average membrane GP for
each experimental condition.RESULTS
GP of di-4-ANEPPDHQ in CHO-K1/A5, a
mammalian cell line expressing muscle-type
AChR
Di-4-ANEPPDHQ was introduced into the membrane field
as an environmentally sensitive styryl fluorescent probe,
which differentially senses Ld from Lo phases coexisting
in model membranes (32). The probe was subsequently
tested in large unilamellar vesicles and neutrophils (33).
Here, the probe was first used to label the cell surface of a
fibroblast cell line produced in our laboratory, which
robustly expresses adult muscle-type AChR at its plasma-
lemma (4). We employed a dual viewer instrument that
allows the simultaneous recording of two spectrally sepa-
rated signals onto the two halves of the same electron
multiplying CCD. In the case of di-4-ANEPPDHQ, this
corresponds to a blue-edge channel, reporting indirectly
on the Lo regions of the membrane, and a red-edge channel,
corresponding to the Ld phase (32,33). Properly aligned
(Fig. S1), the two channels should provide an almost perfect
two-dimensional map of the spatial distribution of the dye,
whose spectral fingerprints report on the microscopic phase
state of the membrane.
To evaluate whether di-4-ANEPPDHQ can effectively
sense changes in the Chol content of the membrane, cells
were treated with CDx, a Chol-depleting agent widely
used in cell biology (5,27,34). Previous studies from ourBiophysical Journal 105(7) 1601–1611
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for achieving acute depletion of cholesterol with minimal
affectation of CHO-K1/A5 cell viability or functionality
(5). Reduction of the Chol content (Fig. S5) in the mem-
brane in living CHO-K1/A5 cells is associated with a
diminution in the mean GP values of di-4-ANEPPDHQ
(Fig. 1, A–C). This reduction is statistically significant at a
CDx concentration of 15 mM (Fig. 1 C), when total Chol
levels are reduced by at least 50% (34). Interestingly, afterFIGURE 1 Changes in di-4-ANEPPDHQ GP in live AChR-expressing
cells induced by cholesterol depletion or enrichment. (A) Merged fluores-
cence images obtained from the blue- and red-edge channels and the corre-
sponding GP images of control and CDx-treated cells. (B) Histograms of
GP distribution in the plasmalemma of CHO-K1/A5 cells. Distributions
on a pixel basis were obtained from GP values of control and CDx-treated
cells at the indicated concentrations. GP values were normalized (100
pixels) and their distributions were plotted and fitted to Gaussian functions,
corresponding in each case to an individual experiment, thus minimizing
the differences in di-4-ANEPPDHQ distribution (n ¼ 10 cells for each
condition). (C) Mean membrane GP values obtained from the Gaussian
fits to the pixel-based distributions in (B). Graphs show that the mean mem-
brane GP value decreases as a consequence of Chol depletion resulting
from CDx treatment, with a statistically significant drop at a concentration
of 15 mM CDx. (D) Chol enrichment produced by treating cells with
CDx-Chol complex before di-4-ANEPPDHQ staining. Mean GP values
in the plasmalemma in control and CDx-Chol conditions were not statisti-
cally different. (E) fPEG-Chol staining shows that a small but statistically
significant increase (~10%) in cholesterol takes place at the plasmalemma
upon CDx-Chol treatment. Scale bar: 10 mm. (*) p< 0.05. To see this figure
in color, go online.
Biophysical Journal 105(7) 1601–1611CDx treatment the GP images became more homogenous,
regions of the membrane with higher GP being more
affected by Chol depletion (Fig. 1 A). The GP distribution
became narrower after CDx treatment, reflecting the loss
of compartmentalization in the membrane due to Chol
depletion (Fig. 1 B).
In another series of experiments, Chol membrane levels
were augmented by incubation of the cells with Chol-CDx
complexes (5,27) before staining with di-4-ANEPPDHQ.
The probe fPEG-Chol was used to test whether the
enrichment in Chol had actually occurred at the plasma
membrane (see Fig. 1 E). fPEG-Chol is a soluble deriva-
tive of Chol that preferentially partitions into Chol-rich
membrane domains, thus acting as a Chol sensor in cells
(35). A small increase in fPEG-Chol fluorescence (~10%)
was observed upon CDx-cholesterol treatment, with
no significant difference in di-4-ANEPPDHQ GP values
between control and CDx-Chol-treated cells (Fig. 1, D
and E).Cell surface AChR clusters and membrane lipid
composition
In a first series of experiments, CHO-K1/A5 cells were
labeled with the anti-AChR monoclonal antibody mAb
210 and Alexa647-labeled secondary antibody; no bleed-
through between the Alexa647 signal and the two recorded
di-4-ANEPPDHQ channels was observed (Fig. S6), thus
validating the use of this fluorophore for subsequent exper-
iments. Using this staining protocol, AChR clusters became
evident (Fig. 2, A–C), allowing us to differentiate between
regions in the membrane with (Fig. 2 D) or without
AChR aggregates (Fig. 2 E). Taking advantage of this, we
attempted to establish whether there is a correlation
between the antibody-induced surface AChR clusters and
the physical state of the host membrane. For this purpose,
CHO-K1/A5 cells were first labeled with the anti-AChR
monoclonal antibody mAb 210 and Alexa647-labeled sec-
ondary antibody followed by 20 mM di-4-ANEPPDHQ
and imaged. Antibody labeling of AChR at 4C has no ma-
jor effects on membrane properties, because the same mean
GP value was observed in labeled (Fig. 2 F) and unlabeled
cells (Fig. 1 C). In addition, when the mean GP values
obtained from regions of the plasma membrane delimited
(Fig. 2 F, mAb 210þ) or not (Fig. 2 F, mAb 210) by
AChR clusters, they were not found to differ significantly.
At first glance this suggests that AChR clusters are associ-
ated with domains that are similar in membrane composi-
tion, i.e., Chol content, to those in the bulk plasma
membrane. However, the lack of difference is most likely
because the size of these membrane domains is beyond
the resolution of the widefield microscope employed here
(9). In the following experiments, each AChR ROI was
compared with the mean membrane GP, as described in
the Materials and Methods section.
FIGURE 2 GP values in AChR-positive
and -negative regions in the plasma membrane.
CHO-K1/A5 cells were costained with anti-AChR
Alexa647 (A, C, D, and E) and di-4-ANEPPDHQ
(B). Antibody binding (anti-AChR þ Alexa647–
conjugated secondary antibody) induces AChR
clustering, making clearly apparent AChR-rich
spots and areas devoid of AChR (A). Upon align-
ment of the selected regions (example highlighted
by the white rectangle) algorithms were applied
to quantify the degree of colocalization. (B) Corresponding di-4-ANEPPDHQGP image. (C–E) Magnified membrane area. Notice the clear antibody-positive
spots, identified in D as AChR clusters (positive mAb 210 ROIs, yellow) and AChR-negative (mAb 210) membrane areas (E), outlined in red. (F) Mean GP
values obtained from plasma membrane mAb 210þ or mAb 210ROIs, respectively. Scale bar: 10 mm in (A and B) and 1 mm in (C,D, and E). (n¼ 3). To see
this figure in color, go online.
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domains depends on Chol and the integrity of the
cytoskeleton
One of the possible interpretations of the previous results is
that under control conditions surface AChR clusters do not
show a preference for any specific membrane domain. Chol
is one of the main structural components of lipid ordered
domains in the membrane (33) and is an important factor
in stabilizing AChR and determining the mechanism and
rate of AChR endocytosis (34). To evaluate whether Chol
affects the association of AChR with membrane domains,
Chol was depleted by treating cells with 15 mM CDx at
37C for 30 min. At the end of the incubation cells were
stained as in Fig. 2 with anti-AChR-Alexa647 and di-4-
ANEPPDHQ at 4C. Images were processed as described
in Materials and Methods to obtain the distribution of
AChR clusters with respect to the mean GP of the mem-
brane. As previously reported (5), CDx treatment reduced
the number of AChR clusters at the membrane and the
mean membrane GP (Fig. 3, A and B). Almost 90% of
AChR clusters in Chol-depleted cells were localized in
membrane domains with GP values lower than those found
under control conditions (Fig. 3 C). More importantly, Chol
depletion also increased the number of AChR clusters asso-
ciated with GP values lower than the mean membrane GP,
with a concomitant decrease in clusters associated with
higher membrane GP values (Fig. 3 D).
In CHO-K1/A5 cells, binding of the antagonist BTX or
anti-AChR antibodies results in AChR internalization that
occurs independently of clathrin, caveolin, or dynamin,
but requires actin polymerization (7). In contrast, in Chol-
depleted cells AChR internalization proceeds by a ligand-,
clathrin-, and dynamin-independent pathway that is not
affected by disruption of the actin cytoskeleton (34). These
differences led us to investigate whether AChR localization
in plasma membrane regions with different GP values
depends on cytoskeletal integrity. Cyto D was previously
shown to decrease the number of actin stress fibers, which
clumped together; Jaspl induced polymerization of mono-
meric actin into amorphous masses and Lat A triggered a
massive disruption of the stress fibers (34). CHO-K1/A5cells also changed their morphology as a consequence of
actin cytoskeleton disruption; this change is indicative of
the efficacy of the treatment (see (34) and Fig. S7). More-
over, as previously reported (7), disruption of the actin
cytoskeleton by Cyto D inhibits AChR internalization trig-
gered by the antagonist BTX. This was also observed
upon incubation of CHO-K1/A5 cells with Lat A (Fig. 4,
BTX internalization).
Applying the same analysis as in Fig. 3, disruption of the
actin cytoskeleton by Lat A increased the number of AChR
clusters with a mean GP value higher than the mean
membrane GP, with a concomitant decrease in AChR
clusters associated with low GP domains (Fig. 4, A and
B). A similar tendency was observed with Cyto D and Jaspl
treatments, although the dispersion of the data precluded
any statistically significant conclusions (Fig. 4). Changes
in the mean GP value of the plasma membrane were not
detected by incubation with any of the three drugs
(Fig. 4 C). Cytoskeletal disruption produced by Lat
A-induced actin depolymerization leads to the redistribution
of AChR (nano)clusters in a manner opposite to that
observed with Chol depletion (Fig. 3).Association of surface and internalized AChR
with lipid domains
Binding of the antagonist BTX induces AChR internaliza-
tion with a time constant of 1.98 h (5,7). We then evaluated
the localization of the AChR clusters remaining at the cell
surface after ligand-induced endocytosis associated with
lipid domains having different GP values. Cells were treated
with cold BTX, incubated at 37C for 2 h to allow for AChR
internalization, and finally stained with the monoclonal anti-
body mAb 210/ Alexa647-labeled secondary antibody and
di-4-ANEPPDHQ (Fig. 5 A). The internalization triggered
by BTX did not modify the distribution in lipid domains
of those AChRs remaining at the cell surface (Fig. 5 B).
Similarly, no modifications in the mean GP of the plasma-
lemma were detected upon BTX binding and subsequent
AChR internalization (Fig. 5 C). Therefore, neither antago-
nist binding nor an endocytosis-mediated decrease in theBiophysical Journal 105(7) 1601–1611
FIGURE 4 Actin cytoskeleton integrity affects the distribution of the
AChR in areas with different GP values. Cells were incubated at 37C
for 2 h with Cyto D, Jaspl, and Lat A, three drugs that affect the actin cyto-
skeleton, and dimethyl sulphoxide as control. (A) Control and Lat A-treated
cells, stained and analyzed as in Fig. 3 A. BTX internalization: Cells were
stained with Alexa647BTX and then incubated at 37C for 2 h. As shown in
the image, Lat A treatment inhibits AChR internalization. (B) Statistically
significant differences in the distribution of AChR were observed upon Lat
A treatment. (C) The drugs used to alter the integrity of the actin cyto-
skeleton did not affect the mean GP of the membrane. Scale bar in (A):
10 mm in images with a white rectangle and BTX internalization images,
and 1 mm in magnified images. (*) p < 0.05. (n ¼ 3). To see this figure
in color, go online.
FIGURE 3 AChR distribution in areas with different GP values is
affected by Chol depletion. (A) CHO-K1/A5 cells costained with anti-
AChR Alexa647 (mAb 210) and di-4-ANEPPDHQ as in Fig. 2 (control
versus Chol depletion). Regions of the cell-surface membrane on which
the analysis was carried out are highlighted with a white rectangle.
AChR clusters associated with areas having GP values lower than the
mean GP of the cell membrane are outlined in white; AChR clusters with
higher-than-the-mean GP are outlined in red. (B) As expected, CDx treat-
ment also reduced mean membrane GP, as a result of Chol depletion. (C)
Histograms of GP values obtained from the underlying plasmalemma of
AChR clusters and fitted as the sum of two Gaussian functions. (D)
AChR clusters with mean GP lower, higher, or equal to the mean membrane
GP. An increase in AChR clusters associated with regions having mean GP
lower than the membrane resulted from CDx treatment. Scale bar in (A): 10
mm in images with a white rectangle, and 1 mm in magnified images. (*) p<
0.05, (**) p < 0.01. (n ¼ 3). To see this figure in color, go online.
1606 Kamerbeek et al.number of surface AChRs affects receptor distribution in
membrane domains with different GP values.
The possible effects of agonist binding were then investi-
gated. Continued exposure to a high concentration of
agonist leads to AChR desensitization. CHO-K1/A5 cells
were incubated with the agonists Nic and Carb for 30 andBiophysical Journal 105(7) 1601–161150 min, respectively, before antibody and di-4-ANEPPDHQ
staining as in Fig. 2. As shown in Fig. 5, after agonist-
induced receptor desensitization, no changes in the mean
GP value of the plasmalemma (Fig. 5 C) or the AChR
distribution in membrane domains could be observed
(Fig. 5 B).
Results on AChR cluster distribution shown in Figs. 3, 4,
and 5, are summarized in Table 1.
We next evaluated the fate of internalized AChR and its
association with intracellular membrane compartments.
Cells were labeled with di-4-ANEPPDHQ at 4C, followed
by incubation at 37C for 2 h to allow receptor internaliza-
tion. At the end of the incubation, di-4-ANEPPDHQ was
found in small vesicles and in an internal central compart-
ment (Fig. 6 A, di-4-ANEPPDHQ, arrow and arrowhead,
respectively). The vesicles emitted predominantly at the
red-edge channel (Fig. 6 A, 575 nm/680 nm, arrow),
whereas di-4-ANEPPDHQ present in the central compart-
ment emitted predominantly at the blue-edge channel
(Fig. 6 A, 575 nm/680 nm, arrowhead). As a consequence,
the vesicles had low GP and the central compartment had
FIGURE 5 Neither AChR internalization induced by BTX nor agonist
treatment affects AChR distribution between high and low GP regions.
(A) Incubation with and without BTX was carried out at 37C for 2 h. Stain-
ing conditions and image analysis were done as in Fig. 3 A. To verify that
AChR internalization actually occurred within the incubation interval, an
additional control was carried out by staining the cells with Alexa647BTX
during the incubation period (BTX internalization). (B) Distribution of
AChR in areas of di-4-ANEPPDHQ GP higher, lower, or equal to the
mean GP values upon receptor internalization or agonist treatment (Nic
and Carb). No statistically significant differences were observed.
(C) Incubation with BTX, Carb, or Nic did not modify mean GP values
of the membrane. Scale bar: 10 mm (images with white rectangle); 1 mm
(magnified images). (n ¼ 3). To see this figure in color, go online.
TABLE 1 Modifications produced in CHO-K1/A5 cells after
treatment with different drugs
Drug
treatment
Mean membrane GP vs.
control condition
Predominant location of AChR
clusters vs. control condition
Lower
GP
Higher
GP
Without
change
Lower
GP
Higher
GP
Without
change
CDx X X
Cyto D X X
Jaspl X X
Lat A X X
BTX X X
Nic X X
Carb X X
AChR Distribution in Membrane Domains 1607high GP (Fig. 6 A, GP, black arrow and arrowhead, respec-
tively). This difference in the order of the membranes may
reflect differences in the Chol content of these compart-
ments. To test this, cells were incubated at 37C for 2 h
with the fluorescent Chol probe fPEG-Chol. Because di-4-
ANEPPDHQ and fPEG-Chol costaining would cause spec-
tral bleed-through, experiments could not be undertaken
with the two probes simultaneously. fPEG-Chol bound to
plasma membrane is slowly internalized into endosomes
together with lipid raft markers via a clathrin-independent
pathway (7,35). As shown in Fig. 6 A, after 2 h at 37C
fPEG-Chol is present in the plasma membrane and in an in-
ternal compartment (arrowhead), with morphology similar
to that of the di-4-ANEPPDHQ-containing compartment,
suggesting that the higher GP of this compartment is related
to higher Chol content. Thus, as in the plasmalemma, di-4-
ANEPPDHQ GP appears to be a reliable probe of biophys-
ical properties of membrane compartments and mirrors their
Chol content.
A staining protocol was then devised to visualize exclu-
sively the fluorescent-labeled AChR and di-4-ANEPPDHQpresent in the membrane at the beginning of the experiment.
For this purpose cells were incubated with Alexa647BTX
and di-4-ANEPPDHQ at 4C, followed by incubation at
37C for 2 h to allow internalization of both probes. This
staining protocol enabled the visualization of internalized
AChR in BTX-labeled individual vesicles (Fig. 6 B, BTX,
arrow), 40% of which also exhibited di-4-ANEPPDHQ
staining (Fig. 6 B, 680 nm/BTX and 575 nm/BTX, respec-
tively, arrow). These vesicles had mean GP values lower
than that of the plasma membrane (Fig. 6 C). Moreover,
internalized AChR vesicles did not colocalize with fPEG-
Chol, thus confirming that the lower GP of AChR-con-
taining vesicles reflected their lower Chol content (Fig. 6
D, arrow).
CDx treatment accelerates AChR endocytosis (34) and
changes the distribution of surface AChR in cell-surface
domains (Fig. 3). To test whether these changes were also
present in internalized AChR, cells were incubated with
BTX and fPEG-Chol and shifted to 37C for 30 min in
the presence or absence of CDx. In control cells, fluorescent
BTX and fPEG-Chol were poorly internalized (Fig. 6 E,
BTX and fPEG-Chol, control). In contrast, in CDx-treated
cells AChR was internalized in small vesicles, only 12%
of which colocalized with fPEG-Chol (Fig. 6 E, BTX,
CDx). Moreover, total fPEG-Chol content was reduced
and most of the label was present in vesicles inside the
cell (Fig. 6 E, fPEG-Chol, CDx). These results suggest
that AChR is internalized in endosomes with low Chol
levels, independently of the endocytic entry route.DISCUSSION
Cell membranes have lateral heterogeneities or lipid
domains that may act as organizing centers for signaling,
providing the requisite concentration of molecules for
efficient signal transduction. The main characteristic of
these heterogeneities is that their lipids are in a more
ordered phase than the bulk lipids of the membrane. The
possibility of assembling/disassembling these domains
adds to the spatiotemporal control over the signaling pro-
cesses (36,37).Biophysical Journal 105(7) 1601–1611
FIGURE 6 Di-4-ANEPPDHQ, fPEG-Chol, and AChR internalization
and their intracellular distribution. (A) CHO-K1/A5 cells were incubated
with di-4-ANEPPDHQ or fPEG-Chol at 4C and shifted to 37C for 2 h.
Di-4-ANEPPDHQ intracellular localization could be seen in a central
compartment (di-4-ANEPPDHQ, arrowhead) or in vesicles (di-4-
ANEPPDHQ, arrow). Corresponding GP image of the cells treated as
above. fPEG-Chol was internalized to a central compartment as with di-
4-ANEPPDHQ (arrowhead). Cells were stained with di-4-ANEPPDHQ
and Alexa647BTX (B) or fPEG-Chol and Alexa647BTX (D) at 4C and
shifted to 37C for 2 h. Some AChR vesicles colocalized with the red-
edge channel signal of di-4-ANEPPDHQ but not with the blue-edge signal
(B, 680 nm/BTX and 575 nm/BTX, respectively, arrow). (C) Mean GP
value calculated in AChR vesicles and in the internal compartment
compared with plasma membrane (PM) mean GP. (D) AChR vesicles did
not colocalize with fPEG-Chol (arrow), but the internal compartment did
colocalize. (E) BTX and fPEG-Chol internalization was evaluated in the
presence or absence of CDx at 37C for 30 min. In the control condition
a similar pattern of internalization was observed for both probes at
30 min or 2 h (control and Fig. 6 A, fPEG-Chol, respectively). In CDx-
treated cells, BTX and fPEG-Chol were internalized exclusively in vesicles.
Colocalization amounted to ~12%. Scale bar in (A, C, and E): 10 mm, and
1 mm in magnified images. (*) p < 0.05, (**) p < 0.01. (n ¼ 3). To see this
figure in color, go online.
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1608 Kamerbeek et al.Cholesterol is one of the most abundant components of
the lateral heterogeneities of cell membranes in general
and of the postsynaptic membrane of cholinergic synapses
in particular, where it modulates some functional properties
and distribution of the AChR protein (16,26,38). The mech-
anisms by which cholesterol-AChR interactions are finally
translated into the observed changes in the receptor’s ligand
binding affinity, ion channel properties, or distribution are
still not fully understood (16,18,19,38). The main thrust of
this work was to establish whether there is a correlation
between the state of association (clustering) of the AChR
protein and the physical state of Chol-related membrane
domains at the cell membrane. For this purpose, use was
made of di-4-ANEPPDHQ, an environmentally sensitive
styryl fluorescent probe, which reports on the relative pro-
portion of Lo and Ld domains coexisting in model mem-
branes regardless of domain size (32). The fluorescence
emission spectrum of di-4-ANEPPDHQ has been reported
to be blue-shifted by ~60 nm in Lo phases with respect to
Ld phases (32). This property was advantageously exploited
to determine the phase (and indirectly the Chol content) of
the plasma membrane associated with AChR clusters.
Because GP values are intensity ratios, the measurements
are independent of local probe concentration or surface
area (39). The use of fluorescence microscopy with a dual
viewer system provided spatial resolution and circumvented
the distortion of measurements occurring with sequential
imaging caused by the delay in image acquisition. The de-
gree of order of the cell-surface membrane observed in
CHO K1/A5 cells using di-4-ANEPPDHQ was similar to
that measured by fluorescence spectroscopy of isolated
CHO-K1/A5 membranes using the probe Laurdan (25). In
this study we were able not only to quantify but also to
spatially resolve the GP of the AChR-associated membrane
(Fig. 2).
Membrane GP was sensitive to the Chol content of the
membrane, regions of high GP being most affected by
changes in Chol levels (Fig. 1 A). This was expected, as
regions of high GP correspond to more ordered membrane
domains, with higher Chol content (33). Removing Chol
led to changes in GP distribution: the curve was shifted to
the left, became narrower, and could be fitted more accu-
rately with a single Gaussian function (Fig. 1 B). The
mean GP of the membrane decreased, demonstrating that
on a pixel basis di-4-ANEPPDHQ GP imaging provides a
good estimate of Chol content (23,32,33).
AChR is present at the plasma membrane of CHO-K1/A5
cells in the form of clusters of ~55 nm only resolved by
superresolution microscopy (9,10). Under control condi-
tions at 4C and in the absence of any external influence
the mean GP of the membrane associated with AChR
clusters did not differ from the mean GP of the membrane
without AChR clusters. This lack of preference was
previously observed with AChR reconstituted in model
membrane systems (40) and in resting C2C12 cells using
AChR Distribution in Membrane Domains 1609Laurdan GP (11). In C2C12 cells, AChR has been reported
to associate with more ordered lipid domains upon agrin
treatment, which triggers the formation of AChR micron-
sized clusters, the stability of these clusters also being
dependent on the association of the AChR with Chol-rich
domains (11,41). Association of AChR with domains of
high lipid order would be subject to regulation by specific
signals. In this regard, AChR organization at the membrane
in CHO-K1/A5 cells does not progress as far as in C2C12
cells because of the lack of muscle-specific signaling/clus-
tering proteins like Musk and rapsyn (5,11). Chol acts as a
stabilizing factor for the AChR in the membrane (18,26)
and its depletion accelerates AChR endocytosis, rerouting
the endocytic trail to an Arf6-dependent pathway (34).
Modification of the AChR stability and route may be the
consequence of altered Chol content in lipid domains asso-
ciated with AChR clusters in the membrane. Indeed, when
cells were Chol-depleted, the distribution of AChR clusters
was altered; AChR clusters associated preferentially with
low GP domains (Fig. 3). These experiments were carried
out after CDx treatment, when half the AChR were already
internalized, thus affecting the population of AChRs
remaining at the cell surface. Interestingly, AChR is inter-
nalized in vesicles that do not colocalize with the fluorescent
Chol analog fPEG-Chol and have lower GP than the plasma
membrane (Fig. 6). This is independent of the endocytic
route followed by the AChR, because the same phenomenon
is observed in Chol-depleted cells, where AChR follows a
different endocytic pathway (34).
In another series of experiments the Chol content of the
intracellular compartments was probed with fPEG-Chol
under conditions in which only the plasma membrane was
labeled (see Material and Methods), thus measuring inter-
nalized Chol arising exclusively from the cell surface mem-
brane. The results suggest that the association of AChR with
domains of lower GP (i.e., lower Chol content) favors
endocytosis. Given the weight of evidence in support of
the role of Chol as an AChR stabilizing factor (16,18,26),
the possibility that AChR clusters remaining at the surface
are associated with domains with lower GP is less likely.
As with other proteins (42,43), distribution of surface
AChR clusters in lipid domains is independent of AChR
surface levels. When cells are labeled with BTX and 50%
of AChR is internalized, the distribution of AChR in lipid
domains is similar to that in cells where AChR is not inter-
nalized (Fig. 5). This suggests that AChR molecules
contribute to the organization of the lipids that surround
them, a contention that has been developed on the basis of
considerable experimental evidence accumulated in the
course of the last two decades (19,26).
Other factors like Chol availability or association with the
cytoskeleton are required for organization of the AChR lipid
environment. Actin disruption modifies the distribution of
AChR clusters in lipid domains. Treatment with Lat A, a
drug that binds to actin monomers and prevents theirincorporation into new filaments (44,45), results in the asso-
ciation of the AChR with domains with higher GP (Fig. 4).
This implies that the distribution of surface AChR in lipid
domains is indeed regulated by the actin cytoskeleton. Other
signaling proteins like G-protein coupled receptors (46,47),
ERK (48), and Src families kinases (49) show a similar
regulation by actin and it was proposed that association/
dissociation with ordered lipid domains serves to control
the transduction of the signal. Modifications in AChR clus-
ter distribution by actin cytoskeleton disruption could be the
consequence of alterations in the structure of lipid domains
and/or impaired interactions between actin cytoskeleton and
the AChR. Actin cytoskeleton has been observed to impart
order to membrane lipids (50,51) and it was proposed that
actin may function as a structuring factor of lipid domains
in cells (52). However, we detected no difference in the
mean GP of the plasma membrane after actin disruption
with any of the drugs tested (Fig. 4 C). Thus, in our system
actin disruption does not appear to induce a global change in
the fluidity of the membrane, suggesting that the structure of
the lipid domains is conserved. Interestingly, AChR inter-
nalization induced by ligand binding is inhibited by disrup-
tion of the actin cytoskeleton (see (7) and Fig. 4). The role of
actin cytoskeleton and its dynamic on AChR stability is
complex and far from clear. Ligand-induced AChR internal-
ization requires actin polymerization (7), but interaction
with actin is necessary to form, stabilize, and maintain a
high order AChR aggregates found in muscle cells in cul-
tures like C2C12 cells (11,53,54).
One take-home lesson from the present results is that
actin cytoskeleton stability is related to AChR organization
at the cell surface. Upon agrin signaling, the structuring
effect of actin on ordered lipid domains allows AChR clus-
ters associated with these domains to coalesce, associate
with clustering proteins, and form the micron-sized aggre-
gates found in C2C12 muscle cells (11,15). In CHO-K1/
A5 cells, coupling of AChR nanoclusters and actin polymer-
ization facilitates AChR internalization (7). If the intact
actin cytoskeleton prevents the association of small AChR
clusters with domains with high GP, it may be assumed
that its disruption will remove this barrier (Fig. 4), the
ensuing association being accompanied by an increase in
the size of AChR nanoclusters (10) and a reduction in the
AChR internalization rate (7).SUPPORTING MATERIAL
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